Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Weatherley

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
British Journal of Clinical Pharmacology|July 1, 1986
Comparative disposition of codeine and pholcodine in man after single oral dosesJ W Findlay, A S Fowle, R F Butz, et al.
British Journal of Clinical Pharmacology|April 1, 1993
The pharmacokinetics, tolerability and pharmacodynamics of tucaresol (589C80; 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid), a potential anti-sickling agent, following oral administration to healthy subjectsP E Rolan, J E Parker, S J Gray, et al.
Clinical Pharmacology and Therapeutics|April 29, 1998
The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and womenR W Peck, E J Seaber, R M Dixon, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
British Journal of Clinical Pharmacology|July 1, 1986
Comparative disposition of codeine and pholcodine in man after single oral dosesJ W Findlay, A S Fowle, R F Butz, et al.
British Journal of Clinical Pharmacology|April 1, 1993
The pharmacokinetics, tolerability and pharmacodynamics of tucaresol (589C80; 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid), a potential anti-sickling agent, following oral administration to healthy subjectsP E Rolan, J E Parker, S J Gray, et al.
Clinical Pharmacology and Therapeutics|April 29, 1998
The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and womenR W Peck, E J Seaber, R M Dixon, et al.
Pageof 4